MORESCO, ROSA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 25.513
EU - Europa 14.169
AS - Asia 12.118
SA - Sud America 1.690
Continente sconosciuto - Info sul continente non disponibili 913
AF - Africa 262
OC - Oceania 31
Totale 54.696
Nazione #
US - Stati Uniti d'America 24.231
SE - Svezia 4.854
SG - Singapore 3.884
IT - Italia 2.834
CN - Cina 2.496
VN - Vietnam 2.271
DE - Germania 1.651
HK - Hong Kong 1.446
RU - Federazione Russa 1.321
BR - Brasile 1.287
CA - Canada 1.063
IE - Irlanda 774
GB - Regno Unito 585
UA - Ucraina 568
BD - Bangladesh 406
FR - Francia 383
IN - India 329
FI - Finlandia 300
KR - Corea 220
AT - Austria 189
TR - Turchia 153
ID - Indonesia 150
AR - Argentina 135
NL - Olanda 128
PL - Polonia 116
IQ - Iraq 113
ES - Italia 107
JP - Giappone 97
ZA - Sudafrica 83
SA - Arabia Saudita 80
DK - Danimarca 78
PK - Pakistan 77
MX - Messico 75
CH - Svizzera 67
EC - Ecuador 61
PH - Filippine 61
CO - Colombia 59
BE - Belgio 44
VE - Venezuela 43
UZ - Uzbekistan 40
JM - Giamaica 39
MA - Marocco 37
CL - Cile 29
IR - Iran 29
EG - Egitto 28
KE - Kenya 28
AE - Emirati Arabi Uniti 27
PY - Paraguay 26
LT - Lituania 25
AU - Australia 24
MY - Malesia 24
CZ - Repubblica Ceca 21
IL - Israele 21
TH - Thailandia 21
TN - Tunisia 20
ET - Etiopia 18
BO - Bolivia 17
DZ - Algeria 17
UY - Uruguay 17
KZ - Kazakistan 16
NP - Nepal 16
PT - Portogallo 16
CR - Costa Rica 15
OM - Oman 15
RO - Romania 15
BG - Bulgaria 14
LB - Libano 14
TW - Taiwan 14
JO - Giordania 13
KG - Kirghizistan 12
NI - Nicaragua 12
HN - Honduras 11
PA - Panama 11
SV - El Salvador 11
AZ - Azerbaigian 10
BH - Bahrain 9
GR - Grecia 9
PS - Palestinian Territory 9
TT - Trinidad e Tobago 9
AL - Albania 8
DO - Repubblica Dominicana 8
EE - Estonia 8
GT - Guatemala 8
HU - Ungheria 8
PE - Perù 8
NZ - Nuova Zelanda 7
SR - Suriname 7
MD - Moldavia 6
AM - Armenia 5
EU - Europa 5
GE - Georgia 5
KW - Kuwait 5
LV - Lettonia 5
MK - Macedonia 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AO - Angola 4
BB - Barbados 4
BY - Bielorussia 4
GA - Gabon 4
Totale 53.702
Città #
Stockholm 3.717
Ann Arbor 3.335
Ashburn 2.696
Singapore 2.368
Hong Kong 1.402
Fairfield 1.401
San Jose 1.360
Woodbridge 1.299
Houston 1.071
Milan 879
Chandler 863
Frankfurt am Main 765
Wilmington 764
Toronto 753
Dublin 744
Ho Chi Minh City 651
Jacksonville 592
New York 584
Seattle 542
Hanoi 529
Santa Clara 525
Dearborn 476
Council Bluffs 448
Cambridge 406
Dallas 397
Los Angeles 388
Beijing 351
Chicago 349
Hefei 345
Princeton 297
The Dalles 256
Nanjing 208
Munich 204
Seoul 202
Rome 201
Lauterbourg 152
Lawrence 141
Vienna 140
Buffalo 137
Columbus 137
Shanghai 135
Altamura 132
Boardman 128
São Paulo 128
Helsinki 124
Moscow 115
Jakarta 105
San Diego 104
Lachine 96
Orem 92
Dong Ket 91
Haiphong 83
London 79
Tokyo 79
Da Nang 78
Phoenix 78
Washington 77
Montreal 75
Guangzhou 69
Brooklyn 63
Shenyang 61
Warsaw 60
Denver 59
Atlanta 56
North Kansas City 51
Nanchang 49
Tianjin 49
Biên Hòa 47
Fremont 46
Jinan 46
Nuremberg 46
Naples 44
Turin 44
Figino 43
Andover 41
Amsterdam 40
Baghdad 40
Changsha 40
Zurich 40
Brussels 39
Hải Dương 39
Salt Lake City 38
Johannesburg 37
Manchester 36
Miami 36
Nürnberg 36
Turku 36
Dhaka 35
Kraków 35
Chennai 34
Falls Church 34
Hebei 34
Tashkent 34
Boston 33
Hangzhou 33
Monza 33
Rio de Janeiro 33
Bologna 31
Philadelphia 31
San Francisco 31
Totale 35.636
Nome #
Micro and nano plastics are everywhere: impact on intestinal inflammation and brain health 1.979
Effects of microplastics and nanoplastics on intestine inflammation 1.958
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player 831
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 712
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 600
99mTc-radiolabeled silica nanocarriers for targeted detection and treatment of HER2-positive breast cancer 575
Development of99mtc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer 569
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 554
Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors 550
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study 542
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 485
Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration 471
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 469
Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models 455
Acute Inescapable Stress Rapidly Increases Synaptic Energy Metabolism in Prefrontal Cortex and Alters Working Memory Performance 451
Radiosynthesis and Preclinical Evaluation of 11C-VA426, a Cyclooxygenase-2 Selective Ligand 443
Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling 441
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 431
From cancer metabolism to new biomarkers and drug targets 418
18 F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis 411
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation 409
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 398
PET imaging and single-cell RNA sequencing glioma microenvironment assessment after RT combined therapy 388
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 374
Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury 373
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 371
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 370
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG 367
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling 367
Preliminary assessment of semiautomated segmentation tool for GBM neurosurgery: a BraTS-Toolkit approach 364
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 359
A systems biology road map for the discovery of drugs targeting cancer cell metabolism 352
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 351
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 349
Role of metformin and AKT axis modulation in the reversion of hypoxia induced TMZ-resistance in glioma cells 349
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 348
Stem Cell-Derived Human Striatal Progenitors Innervate Striatal Targets and Alleviate Sensorimotor Deficit in a Rat Model of Huntington Disease 343
Imaging temozolomide-induced changes in the myeloid glioma microenvironment 343
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195 341
Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model 341
Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using 18F-FDG PET 337
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 333
The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis 330
Characterization of preclinical models of prostate cancer using PET-based molecular imaging 328
Validation of an Engineered Cell Model for In Vitro and In Vivo HIF-1α Evaluation by Different Imaging Modalities 328
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 326
Metabolic evaluation of non-small cell lung cancer patient-derived xenograft models using 18F-FDG PET: A potential tool for early therapy response 325
Basal ganglia and language: Phonology modulates dopaminergic release 316
Ibuprofen plus isosorbide dinitrate treatment in the mdx mice ameliorates dystrophic heart structure 315
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer 314
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis 311
Tumour hypoxia: lessons learnt from preclinical imaging 310
Sperimentazione clinica con radiofarmaci 310
3D Spatial resolution proprieties of Molecubes β-Cube: Characterization with different isotopes 305
Brain sex-dependent alterations after prolonged high fat diet exposure in mice 301
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 299
Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice 299
A Decision Support System for the assisted diagnosis of brain tumors: a feasibility study for ¹⁸F-FDG PET preclinical studies 299
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 299
The peritumoral brain zone in glioblastoma: where we are and where we are going 296
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 295
[11]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with lewy bodies: A Bayesian method and voxel-based analysis 294
Cholinergic activity correlates with reserve proxies in Alzheimer's disease 294
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 292
Modulazione del fenotipo cellulare indotto da radioterapia ipofrazionata in un modello murino di glioma 291
A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset 285
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts 285
The driving role of the Cdk5/Tln1/FAKS732 axis in cancer cell extravasation dissected by human vascularized microfluidic models 285
Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [18F]FDG Positron Emission Tomography and Autoradiography 285
Acute stress studies in rats by 18 FDG PET and SPM 282
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 281
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 280
Quantification of Dynamic [18F]FDG Pet Studies in Acute Lung Injury 278
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity 278
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 276
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 276
PET and SPET molecular imaging: Focus on serotonin system 274
Feasibility of supervised machine learning technique for assisted diagnosis of cancer: application to PET studies in small animals 274
Evaluation of [O-methyl-(11)C]fluvoxamine as a tracer for serotonin re-uptake sites 272
[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer 271
Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mouse 265
Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method 264
Acute effect of 3-(4-acetamido)-butyrril-lorazepam (dds2700) on brain function assessed by pet at rest and during attentive tasks 264
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 263
In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study 263
In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder 260
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 260
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 259
Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells 259
GABAa receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil 258
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 257
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients: Role of free fatty acid and insulin levels 257
Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges 256
Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity 255
Glycine N-Methylation in NGR-Tagged Nanocarriers Prevents Isoaspartate Formation and Integrin Binding without Impairing CD13 Recognition and Tumor Homing 255
Validation and Performance Assessment of a Preclinical SiPM-Based SPECT/MRI Insert 254
An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease 253
Radiosynthesis and preliminary biological evaluation of [18F]VC701, a radioligand for translocator protein 253
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 252
[18f]-(2S,4R)-4-Fluoroglutamine As a New Positron Emission Tomography Tracer in Multiple Myeloma 252
Totale 37.690
Categoria #
all - tutte 161.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.827 0 0 0 287 168 187 144 148 147 183 191 372
2022/20233.717 453 1.022 338 315 285 531 60 203 271 35 113 91
2023/20242.696 114 100 100 136 333 714 484 90 217 65 44 299
2024/20256.490 383 689 513 272 496 299 450 289 627 936 501 1.035
2025/202621.987 2.427 1.264 1.212 1.867 1.927 944 2.294 861 1.382 5.043 1.355 1.411
2026/20273.820 626 753 1.743 698 0 0 0 0 0 0 0 0
Totale 54.696